FRANKFORT, Ky. (WOWK) — Kentucky Governor Andy Beshear announced on Monday that bromazolam, also known as “Designer Xanax,” received an emergency designation as a Schedule I controlled substance.

In the last Fierce Pharma Asia weekly news roundup of 2025, Daiichi Sankyo scored a key FDA approval for AstraZeneca-partnered Enhertu in first-line HER2-positive breast cancer but paused a phase 3 ...

China has been consolidating an ambition to build a world-class pharmaceutical industry. With the emergence of new technologies, collaboration paradigms, and institutional support, the next natural ...

Entrepreneurs and families are turning religious architecture into hands-on learning—blending education, devotion and ...